Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases

• Adam Lauko,
• Rupesh Kotecha,
• Addison Barnett,
• Hong Li,
• Vineeth Tatineni,
• Assad Ali,
• Pradnya Patil,
• Alireza M. Mohammadi,
• Samuel T. Chao,
• Erin S. Murphy,
• Lilyana Angelov,
• John H. Suh,
• Gene H. Barnett,
• Nathan A. Pennell,
• Manmeet S. Ahluwalia

Affiliations

Adam Lauko

Case Western Reserve University School of Medicine MSTP

Rupesh Kotecha

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida

Addison Barnett

Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute

Hong Li

Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic

Vineeth Tatineni

Department of Internal Medicine, Summa Health, Akron City Hospital

Assad Ali

Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute

Pradnya Patil

Department of Medical Oncology, Taussig Cancer Institute, Cleveland Clinic

Alireza M. Mohammadi

Case Western Reserve University School of Medicine MSTP

Samuel T. Chao

Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute

Erin S. Murphy

Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute

Lilyana Angelov

Case Western Reserve University School of Medicine MSTP

John H. Suh

Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute

Gene H. Barnett

Case Western Reserve University School of Medicine MSTP

Nathan A. Pennell

Department of Medical Oncology, Taussig Cancer Institute, Cleveland Clinic

Manmeet S. Ahluwalia

Herbert Wertheim College of Medicine, Florida International University